NCT05553314View on ClinicalTrials.gov

Carvedilol in HF With Preserved EF

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 17, 2021

Primary Completion Date

August 30, 2024

Study Completion Date

December 30, 2024

Conditions
Heart Failure With Preserved Ejection FractionBeta BlockerMyocardial Strain
Interventions
DRUG

Carvedilol

patients randomized to carvedilol group will receive carvedilol-SR.

DRUG

Placebo

patients randomized to placebo group will receive placebo.

Trial Locations (2)

26426

RECRUITING

Wonju Severance Christian Hospital, Wŏnju

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
collaborator

Samsung Medical Center

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

lead

Seoul National University Bundang Hospital

OTHER